1 Top Management and Board of Directors; 2 INSIDER BUYING; 3 Peer Comparison & Ranking of TSCO
Top Management and Board of Directors
Top Management Top Management [Six top executives with tenure > 8 yrs]
Name | Designation | Since Appointment | Robert Welch | Company Secretary | 8 Yrs, 1 Mo | Ken Murphy | Chief Executive Officer, Executive Director | - | Gerry Murphy | Independent Non-Executive Chairman | - | Imran Nawaz | Chief Financial Officer, Executive Director | - | Guus Dekkers | Chief Technology Officer | - | Ashwin Prasad | Chief Product Officer | - |
Board Of Directors Board Of Directors [Nine directors with tenure < 4 yrs]
Name | Designation | Since Appointment | Karen Whitworth | Non-Executive Director | 3 Yrs, 8 Mos | Stewart Charles Gilliland | Independent Non-Executive Director | - | Carolyn Fairbairn | Independent Non-Executive Director | - | Bertrand Bodson | Independent Non-Executive Director | - | Byron Grote | Independent Non-Executive Director | - | Caroline Silver | Independent Non-Executive Director | - | Thierry Garnier | Independent Non-Executive Director | - | Melissa W. Bethell | Independent Non-Executive Director | - | Alison Platt | Non-Executive Director | - |
INSIDER BUYING Insider buying Summary in the past 12 months
Name | No. of Shares | Price, GBP | Value, GBP | Gerry Murphy [Independent Non-Executive Chairman] | 50,000 | 2.8 | 138,138 | Carolyn Fairbairn [Independent Non-Executive Director] | 35,000 | 3.0 | 104,842 | Ken Murphy [CEO] | 588 | 3.0 | 1,735 | Total | 85,588 | 2.9 | 244,715 |
Peer Comparison & Ranking of TSCO PEER COMPARISON: TSCO IN INDICES
Tesco is a constituent of the following indices.
Its market capitalisation is $33 billion and accounts for 1.1% of the combined MCap of the FTSE 100 Index.
Index Name | MCap of Index ($ b) | TSCO MCap as % of Index | FTSE 100 Index | 2,904 | 1.1 | FTSE 350 Index | 3,372 | 1.0 | FTSE All-Share Index | 3,461 | 1.0 |
GLOBAL PEER COMPARISON: TSCO - SIZE (all figures in $)
In its Global Peer Group of 9 companies TSCO is ranked third (3) by Total Assets, fourth (4) by MCap, Revenue and fifth (5) by Net Profit.
Name (Code) | MCap | Revenue | Net Profit | Total Assets | Rank of TSCO | 4 | 4 | 5 | 3 | Tesco (TSCO) | 33B | 89.8B | 1.6B | 61.9B | Walmart (WMT) | 625.1B | 648.1B | 15.5B | 252.4B | Target (TGT) | 72.5B | 107.4B | 4.1B | 55.4B | Japan Tobacco (2914) | 57.7B | 20B | 3.4B | 51.4B | Ajinomoto (2802) | 20B | 10.2B | 614.6M | 12.5B | Asahi Group (2502) | 19.7B | 19.5B | 1.2B | 37.3B | Wilmar International (F34) | 15.3B | 67.2B | 1.5B | 61.8B | Kirin Holdings (2503) | 14.1B | 15.1B | 795M | 20.2B | Carrefour (CA) | 12.4B | 94.4B | 1.8B | 62.4B |
GLOBAL PEER COMPARISON: TSCO - RELATIVE VALUE INDICATORS
In value terms, comparing relative value of its shares, TSCO is ranked
+ 4 out of 9 by Dividend Yield (%) [3.3] + 7 out of 9 by Price/Earnings per share [21.7] + 3 out of 9 by Price/Sales per share [0.4] + 6 out of 9 by Price/Book value per share [22.5]
Name (Code) | Currency Code | Last Price | Div Yld (%) | P/E | P/S | P/Book | Rank of TSCO by value | | | 4 | 7 | 3 | 6 | Tesco (TSCO) | GBX | 365.5 | 3.3 | 21.7 | 0.4 | 22.5 | Walmart (WMT) | USD | 77.8 | 1.0 | | 1.0 | 14.9 | Target (TGT) | USD | 156.7 | 2.9 | 18.0 | 0.7 | 5.3 | Japan Tobacco (2914) | JPY | 4,093 | 4.7 | 15.1 | 2.9 | 7.5 | Ajinomoto (2802) | JPY | 5,358 | 1.4 | 32.0 | 2.0 | 4.4 | Asahi Group (2502) | JPY | 5,532 | 2.3 | 17.1 | 1.0 | | Wilmar International (F34) | SGD | 3.2 | 5.3 | 10.1 | 0.2 | | Kirin Holdings (2503) | JPY | 2,182.5 | 3.2 | 15.7 | 0.9 | 2.7 | Carrefour (CA) | EUR | 15.7 | 5.5 | 8.6 | 0.1 | |
USD 1= 75.765884 Pence Sterling (GBX); 141.950995 Japanese Yen (JPY); 1.295 Singapore Dollar (SGD); 0.899586 Euro (EUR)
BUYSELLSIGNALS FUNDAMENTALS VALUATION RANKING: Tesco vs United Kingdom Market
Out of 1,066 stocks and 67 units in the United Kingdom Market, Tesco is ranked third(3) by Revenue, thirteenth(13) by Free Cash Flow, Fortieth(40) by Market Cap in $ and Sixty-third(63) by P/Sales.
| United Kingdom Avg | TSCO | TSCO Rank | Revenue $ | 3.2 B | 90 B | 3 | Free Cash Flow | (332.4 M) | 2.8 B | 13 | Market Cap $ | 5.4 B | 33 B | 40 | P/Sales | 1.4x | 0.4x | 63 | Net Profit $ | 296.4 M | 1.6 B | 64 | P/Earnings/ Growth | - | 30.7x | 83 | Yield (%) | 2.3 | 3.3 | 277 | P/Earnings | 14.7x | 21.5x | 341 | Price/Net Tangible Assets | 2.1x | 22.3x | 640 | ROA (%) | 1.5 | 3.8 | 662 | EBITDA Margin% | 14.8 | 3.4 | 700 | Premium to 52-Wk Low (%) | 87.4 | 47.2 | 815 | Total Debt/Equity (the lower the better) | 0.6x | 1.3x | 1052 | Discount to 52-Wk High (%) | 2.7 | 2.2 | 1054 | Negative values are shown in brackets.
MARKET SHARE Tesco has a position of market dominance in the Food & Drug Retailers sector. Tesco vs Food & Drug Retailers sector [Food & Drug Retailers sector Total in Brackets] Revenue of GBP68.2 billion ($90 billion)[64.5% of aggregate sector revenue of GBP105.7 billion; down from 64.7% in the previous year.]
GLOBAL RANK [out of 46,921 stocks] AND RANK OF TESCO IN THE EUROPE REGION [out of 7,336 stocks]
Description | Value | Global Rank | In Eur Region | MCap ($) | 33B | 626 | 126 | Total Assets ($) | 61.9B | 890 | 194 | Revenue ($) | 89.8B | 156 | 41 | Net Profit ($) | 1.6B | 928 | 200 | Return on Equity % | 15.1 | 7,683 | 1,428 | Net Profit Margin % | 2.6 | 23,387 | 3,471 | Price to Book | 22.5 | 35,370 | 4,624 | Price/Earnings | 21.7 | 15,580 | 2,193 | Yield % | 3.3 | 9,271 | 1,581 | PV1000 (1Year) $* | 1,546 | 5,848 | 889 | $* Change (1Year) % | 50.0 | 6,171 | 915 |
* 1 year ago GBP 1 = $ 1.24 Sep 19, 2024: GBP 1 equals $ 1.32
RANK OF TESCO IN THE FTSE 100 INDEX [out of 93 stocks], IN THE UNITED KINGDOM MARKET [out of 1161 stocks] AND IN THE FOOD & DRUG RETAILERS SECTOR [out of 4 stocks]
Description | Value | In FTSE 100 Index | In United Kingdom Market | In Food & drug retailers sector | MCap (GBP) | 25B | 25 | 30 | 1 | Total Assets (GBP) | 47B | 23 | 34 | 1 | Revenue (GBP) | 68.2B | 2 | 5 | 1 | Net Profit (GBP) | 1.2B | 27 | 34 | 1 | Return on Equity % | 15.1 | 35 | 239 | 2 | Net Profit Margin % | 2.6 | 79 | 665 | 2 | Price to Book | 22.3 | 55 | 987 | 4 | Price/Earnings | 21.5 | 47 | 471 | 1 | Yield % | 3.3 | 37 | 311 | 2 | PV1000 (1Year) GBX | 1,452 | 14 | 145 | 1 |
LONG-TERM FUNDAMENTAL RANKING: 3 OUT OF 5 [5 is best] Tesco is ranked number 1 out of 8 listed food & drug retailers companies in the United Kingdom with a market capitalization of GBP25 billion ($33 billion).
It has a strong relative ROE of 15.1% and ROA of 3.8%. The company paid a dividend of GBX8.25 in the last twelve months. The dividend yield is high at 3.3%. Finally, its earnings growth in the past 12 months has been a comparatively high 70%. Stocks are scored on a set of parameters reflecting fundamental analytical tools involving valuation, size and financial performance. They are ranked according to the average values of those parameters. The highest ranking is 5 and the lowest ranking is 1.
1 Dividend; 2 Financials as Reported FY 2024
Dividend Dividend History In the past 5 years annual dividends have increased by GBX0.5 from GBX11.6 to GBX12.1. Based on a start date of 5 years ago, there has been two decline in dividends over the last 5 years.
Date Paid | Value (GBP) | Type | 16 May 2024 | 8.25 | Final | 12 Oct 2023 | 3.85 | Interim | Tr 12 Months | 12.1 | | 2022 - 2023 | 10.9 | | 2021 - 2022 | 10.9 | | 2020 - 2021 | 74.51 | | 2019 - 2020 | 11.59 | |
Financials as Reported FY 2024 Financials as reported (FY 2024 [year-ended 24 February 2024 ])
RESULTS OF OPERATIONS AND FINANCIAL CONDITION (In GBP Million, except per share data and shares outstanding)
INCOME STATEMENT AS REPORTED (FY 2024 [year-ended 24 February 2024 ])
Description | GBP Million | GBP Million | | | Feb 24, 2024 | Dec 25, 2023 | Change % | Continuing operations | | | | Revenue from sale of goods and services | 67,673 | 64,864 | Up 4.3 | Insurance revenue | 514 | 458 | Up 12.2 | Revenue | 68,187 | 65,322 | Up 4.4 | Cost of sales | -62,836 | -61,516 | Deterioration 2.1 | Insurance service expenses | -454 | -408 | Deterioration 11.3 | Net expenses from reinsurance contracts held | -48 | -37 | Deterioration 29.7 | Gross profit/(loss) | 4,849 | 3,361 | Up 44.3 | Administrative expenses | -2,028 | -1,951 | Deterioration 3.9 | Operating profit/(loss) | 2,821 | 1,410 | Up 100.1 | Share of post-tax profits of joint ventures and associates | 6 | 8 | Down 25.0 | Finance income | 267 | 87 | Up 206.9 | Finance costs | -805 | -623 | Deterioration 29.2 | Profit/(loss) before tax from continuing operations | 2,289 | 882 | Up 159.5 | Taxation | -525 | -224 | Deterioration 134.4 | Profit/(loss) for the year from continuing operations | 1,764 | 658 | Up 168.1 | Discontinued operations | | | | Profit/(loss) for the year from discontinued operations | -572 | 78 | Deterioration | Profit/(loss) for the year | 1,192 | 736 | Up 62.0 | Attributable to: | | | | Owners of the parent | 1,188 | 737 | Up 61.2 | Non-controlling interests | 4 | -1 | Recovery | | 1,192 | 736 | Up 62.0 | Earnings per share from continuing and discontinued operations | | | | Basic | 17.0 GBX | 10.0 GBX | Up 70.0 | Diluted | 17.0 GBX | 10.0 GBX | Up 70.0 | Earnings per share from continuing operations | | | | Basic | 25.0 GBX | 9.0 GBX | Up 177.8 | Diluted | 25.0 GBX | 9.0 GBX | Up 177.8 | Weighted average number of ordinary share Basic | 7,097,000,000 | 7,415,000,000 | Down 4.3 | Weighted average number of ordinary share Diluted | 7,176,000,000 | 7,482,000,000 | Down 4.1 |
BALANCE SHEET AS REPORTED (FY 2024 [year-ended 24 February 2024 ])
Description | GBP Million | GBP Million | | | Feb 24, 2024 | Dec 25, 2023 | Change % | Non-current assets | | | | Goodwill and other intangible assets | 5,066 | 5,375 | Down 5.7 | Property plant and equipment | 17,221 | 16,862 | Up 2.1 | Right of use assets | 5,478 | 5,500 | Down 0.4 | Investment property | 24 | 24 | Steady | Investments in joint ventures and associates | 102 | 93 | Up 9.7 | Other investments | 1,546 | 1,339 | Up 15.5 | Trade and other receivables | 36 | 79 | Down 54.4 | Loans and advances to customers | | 3,029 | | Reinsurance contract assets | 125 | 135 | Down 7.4 | Derivative financial instruments | 781 | 873 | Down 10.5 | Post-employment benefit surplus | 22 | 6 | Up 266.7 | Deferred tax assets | 32 | 84 | Down 61.9 | | 30,433 | 33,399 | Down 8.9 | Current assets | | | | Other investments | 206 | 353 | Down 41.6 | Inventories | 2,635 | 2,510 | Up 5.0 | Trade and other receivables | 1,349 | 1,235 | Up 9.2 | Loans and advances to customers | | 3,948 | | Derivative financial instruments | 55 | 57 | Down 3.5 | Current tax assets | 110 | 63 | Up 74.6 | Short-term investments | 2,128 | 1,628 | Up 30.7 | Cash and cash equivalents | 2,340 | 2,465 | Down 5.1 | | 8,823 | 12,259 | Down 28.0 | Assets of the disposal group and non-current assets classified as held for sale | 7,783 | 210 | Up 3,606.2 | | 16,606 | 12,469 | Up 33.2 | Current liabilities | | | | Trade and other payables | -10,264 | -9,762 | Deterioration 5.1 | Borrowings | -1,536 | -1,770 | Improved 13.2 | Lease liabilities | -584 | -595 | Improved 1.8 | Provisions | -306 | -366 | Improved 16.4 | Insurance contract liabilities | -526 | -501 | Deterioration 5.0 | Customer deposits and deposits from banks | -108 | -4,485 | Improved 97.6 | Derivative financial instruments | -25 | -99 | Improved 74.7 | Current tax liabilities | -1 | -18 | Improved 94.4 | | -13,350 | -17,596 | Improved 24.1 | Liabilities of the disposal group classified as held for sale | -7,122 | -14 | Deterioration 50,771.4 | | -20,472 | -17,610 | Deterioration 16.3 | Net current liabilities | -3,866 | -5,141 | Improved 24.8 | Non-current liabilities | | | | Trade and other payables | -39 | -54 | Improved 27.8 | Borrowings | -5,683 | -5,581 | Deterioration 1.8 | Lease liabilities | -7,038 | -7,132 | Improved 1.3 | Provisions | -175 | -194 | Improved 9.8 | Customer deposits and deposits from banks | -800 | -2,265 | Improved 64.7 | Derivative financial instruments | -241 | -288 | Improved 16.3 | Post-employment benefit deficit | -657 | -400 | Deterioration 64.2 | Deferred tax liabilities | -269 | -119 | Deterioration 126.1 | | -14,902 | -16,033 | Improved 7.1 | Net assets | 11,665 | 12,225 | Down 4.6 | Equity | | | | Share capital | 445 | 463 | Down 3.9 | Share premium | 5,165 | 5,165 | Steady | Other reserves | 3,131 | 3,139 | Down 0.3 | Retained earnings | 2,930 | 3,469 | Down 15.5 | Equity attributable to owners of the parent | 11,671 | 12,236 | Down 4.6 | Non-controlling interests | -6 | -11 | Improved 45.5 | Total equity | 11,665 | 12,225 | Down 4.6 |
CASH FLOW AS REPORTED (FY 2024 [year-ended 24 February 2024 ])
Description | GBP Million | GBP Million | | | Feb 24, 2024 | Dec 25, 2023 | Change % | Cash flows generated from/(used in) operating activities | | | | Operating profit/(loss) of continuing operations | 2,821 | 1,410 | Up 100.1 | Operating profit/(loss) of discontinued operations | -659 | 98 | Deterioration | Depreciation and amortisation | 1,723 | 1,700 | Up 1.4 | (Profit)/loss arising on sale of property plant and equipment investment property intangible assets assets classified as held for sale and early termination of leases | -53 | -76 | Improved 30.3 | (Profit)/loss arising from sale of other investments | | 3 | | (Profit)/loss arising on sale of joint ventures and associates | -9 | | | (Profit)/loss arising on sale of subsidiaries | -12 | | | Net impairment (reversal)/loss on property plant and equipment right of use assets intangible assets and investment property | -28 | 982 | Deterioration | Net remeasurement loss on non-current assets held for sale | 720 | 23 | Up 3,030.4 | Defined benefit pension scheme payments | -29 | -23 | Deterioration 26.1 | Share-based payments | 78 | 59 | Up 32.2 | Fair value movements included in operating profit/(loss) | 71 | 70 | Up 1.4 | Retail (increase)/decrease in inventories | -150 | -147 | Deterioration 2.0 | Retail (increase)/decrease in trade and other receivables | -118 | -54 | Deterioration 118.5 | Retail increase/(decrease) in trade and other payables | 714 | 643 | Up 11.0 | Retail increase/(decrease) in provisions | -72 | 75 | Deterioration | Retail (increase)/decrease in working capital | 374 | 517 | Down 27.7 | Tesco Bank (increase)/decrease in loans and advances to customers | -714 | -690 | Deterioration 3.5 | Tesco Bank (increase)/decrease in trade reinsurance and other receivables | -9 | 83 | Deterioration | Tesco Bank increase/(decrease) in customer and bank deposits trade insurance liabilities and other payables | 584 | 348 | Up 67.8 | Tesco Bank increase/(decrease) in provisions | 28 | -7 | Recovery | Tesco Bank (increase)/decrease in working capital | -111 | -266 | Improved 58.3 | Cash generated from/(used in) operations | 4,886 | 4,497 | Up 8.7 | Interest paid | -824 | -652 | Deterioration 26.4 | Corporation tax paid | -223 | -123 | Deterioration 81.3 | Net cash generated from/(used in) operating activities | 3,839 | 3,722 | Up 3.1 | Cash flows generated from/(used in) investing activities | | | | Proceeds from sale of property plant and equipment investment property intangible assets and assets classified as held for sale | 55 | 342 | Down 83.9 | Purchase of property plant and equipment investment property and other long-term assets | -1,108 | -971 | Deterioration 14.1 | Purchase of intangible assets | -278 | -279 | Improved 0.4 | Disposal of subsidiaries net of cash disposed | 15 | | | Acquisition of subsidiaries net of cash acquired | -17 | -71 | Improved 76.1 | Proceeds from sale of joint ventures and associates | 9 | | | Increase in loans to joint ventures and associates | -61 | -1 | Deterioration 6,000.0 | Investments in joint ventures and associates | -9 | -10 | Improved 10.0 | Net (investments in)/proceeds from sale of short-term investments | -507 | 451 | Deterioration | Proceeds from sale of other investments | 352 | 230 | Up 53.0 | Purchase of other investments | -390 | -529 | Improved 26.3 | Dividends received from joint ventures and associates | 9 | 14 | Down 35.7 | Interest received | 249 | 70 | Up 255.7 | Cash inflows from derivative financial instruments | 5 | 54 | Down 90.7 | Cash outflows from derivative financial instruments | -24 | -6 | Deterioration 300.0 | Net cash generated from/(used in) investing activities | -1,700 | -706 | Deterioration 140.8 | Cash flows generated from/(used in) financing activities | | | | Own shares purchased for cancellation | -752 | -781 | Improved 3.7 | Own shares purchased for share schemes | -93 | -86 | Deterioration 8.1 | Repayment of capital element of obligations under leases | -627 | -593 | Deterioration 5.7 | Cash outflows exceeding the incremental increase in assets in a property buyback | -62 | -21 | Deterioration 195.2 | Increase in borrowings | 1,232 | | | Repayment of borrowings | -775 | -709 | Deterioration 9.3 | Cash inflows from derivative financial instruments | 98 | 232 | Down 57.8 | Cash outflows from derivative financial instruments | -102 | -371 | Improved 72.5 | Dividends paid to equity owners | -778 | -859 | Improved 9.4 | Net cash generated from/(used in) financing activities | -1,859 | -3,188 | Improved 41.7 | Net increase/(decrease) in cash and cash equivalents | 280 | -172 | Recovery | Cash and cash equivalents at the beginning of the year | 1,565 | 1,771 | Down 11.6 | Effect of foreign exchange rate changes | 29 | -34 | Recovery | Cash and cash equivalents including cash held in the disposal group at the end of the year | 1,874 | 1,565 | Up 19.7 | Less: Cash held in the disposal group | -346 | | | Cash and cash equivalents at the end of the year | 1,528 | 1,565 | Down 2.4 |
|